APA (7th ed.) Citation

AS, B. R., CL, A., A, W., T, Y., C, T., V, G., . . . K, S. (2024). Therapeutic drug monitoring of imatinib - how far are we in the leukemia setting? Expert review of clinical pharmacology, 17(3), 225. https://doi.org/10.1080/17512433.2024.2312256

Chicago Style (17th ed.) Citation

AS, Buhl Rasmussen, Andersen CL, Weimann A, Yang T, Tron C, Gandemer V, Dalhoff K, Rank CU, and Schmiegelow K. "Therapeutic Drug Monitoring of Imatinib - How Far Are We in the Leukemia Setting?" Expert Review of Clinical Pharmacology 17, no. 3 (2024): 225. https://doi.org/10.1080/17512433.2024.2312256.

MLA (9th ed.) Citation

AS, Buhl Rasmussen, et al. "Therapeutic Drug Monitoring of Imatinib - How Far Are We in the Leukemia Setting?" Expert Review of Clinical Pharmacology, vol. 17, no. 3, 2024, p. 225, https://doi.org/10.1080/17512433.2024.2312256.